Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Newspaper/Magazine Article

FDA Advise-ERR: prevent dangerous drug-device interaction causing falsely elevated glucose levels.

FDA Advise-ERR: prevent dangerous drug-device interaction causing falsely elevated glucose levels. ISMP Medication Safety Alert! Acute Care Edition. June 19, 2008;13:1-3.

Save
Print
May 2, 2018
ISMP Medication Safety Alert! Acute Care Edition. June 19, 2008;13:1-3.

This article addresses a drug–device interaction in which patients receiving a certain peritoneal dialysis solution may have falsely elevated blood glucose levels when measured with point-of-care blood glucose monitors.

Save
Print
Cite
Citation

FDA Advise-ERR: prevent dangerous drug-device interaction causing falsely elevated glucose levels. ISMP Medication Safety Alert! Acute Care Edition. June 19, 2008;13:1-3.